Lv1
30 积分 2024-11-06 加入
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
6天前
已完结
Histological and functional comparisons of four anatomical regions of porcine skin with human abdominal skin
1个月前
已完结
Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics
3个月前
已完结
Sequencing Orbitides by Acid-Mediated Ring Cleavage Followed by Tandem Mass Spectrometry
3个月前
已完结
Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials
3个月前
已完结
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
3个月前
已完结
Effects of once-weekly subcutaneous retatrutide on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials
3个月前
已关闭
Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials
3个月前
已完结
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
3个月前
已完结
Quantification of orally administered chondroitin sulfate oligosaccharides in human plasma and urine
3个月前
已完结
皖公网安备34019202002308
